Most importantly, we have demonstrated that the function of its protomers is strictly controlled by the formation of the dimer, as neither CXCR4 nor CCR7 activation could be detected in non-invasive mammary tumour cells, where the presence of the heterodimeric CXCR4-CCR7 receptor was not found. The gene discussed is CCR7; the disease is breast cancer.